Læknaneminn - 01.04.2021, Side 33

31 Slagsmál við tímann
association/American stroke association.
Stroke. 2013;44(7):2064–89.
36. Ng YS, Stein J, Ning MM, Black-Schaffer
RM. Comparison of clinical characteristics
and functional outcomes of ischemic
stroke in different vascular territories.
Stroke. 2007;38(8):2309–14.
37. Gibo H, Carver CC, Rhoton AL, Lenkey
C, Mitchell RJ. Microsurgical anatomy of
the middle cerebral artery. J Neurosurg.
1981;54(2):151–69.
38. Heilman K, Valenstein E, Watson R.
Neglect and related disorders. Semin
Neurol. 2000;20(4).
39. Alexander MP, Hillis AE. Chapter 14
Aphasia. Vol. 88, Handbook of Clinical
Neurology. Elsevier; 2008. p. 287–309.
40. Gibson LM, Whiteley W. The differential
diagnosis of suspected stroke: A
systematic review. J R Coll Physicians
Edinb. 2013;43(2):114–8.
41. Group NI of ND and S rt-PSS. Tissue
plasminogen activator for acute ischemic
stroke. N Engl J Med. 1995;333(24).
42. Marler JR, Tilley BC, Lu M, Brott TG,
Lyden PC, Grotta JC, et al. Early stroke
treatment associated with better
outcome: The NINDS rt-PA Stroke Study.
Neurology. 2000;55(11):1649–55.
43. Hacke W. Intravenous thrombolysis
with recombinant tissue plasminogen
activator for acute hemispheric stroke.
The European Cooperative Acute Stroke
Study (ECASS). JAMA J Am Med Assoc.
1995;274(13):1017–25.
44. Hacke W, Kaste M, Fieschi C, Von
Kummer R, Davalos A, Meier D, et al.
Randomised double-blind placebo-
controlled trial of thrombolytic therapy
with intravenous alteplase in acute
ischaemic stroke (ECASS II). Lancet.
1998;352(9136):1245–51.
45. Clark WM, Wissman S, Albers GW,
Jhamandas JH, Madden KP, Hamilton S.
Recombinant tissue-type plasminogen
activator (Alteplase) for ischemic
stroke 3 to 5 hours after symptom onset
the ATLANTIS study: A randomized
controlled trial. J Am Med Assoc.
1999;282(21):2019–26.
46. Clark WM, Albers GW, Madden KP,
Hamilton S. The rtPA (Alteplase) 0-
to 6-Hour Acute Stroke Trial, Part A
(A0276g). 2000;31(4):811–6.
47. Atlantis T, Study PA, Investigators G.
Association of outcome with early stroke
treatment: Pooled analysis of ATLANTIS,
ECASS, and NINDS rt-PA stroke trials.
Lancet. 2004;363(9411):768–74.
48. Ringleb PA, Bousser MG, Ford G, Bath
P, Brainin M, Caso V, et al. Guidelines
for management of ischaemic stroke
and transient ischaemic attack 2008.
Cerebrovasc Dis. 2008;25(5):457–507.
49. Hacke W, Kaste M, Bluhmki E, Brozman M,
Dávalos A, Guidetti D, et al. Thrombolysis
with Alteplase 3 to 4.5 Hours after
Acute Ischemic Stroke. N Engl J Med.
208AD;359(13):1317–29.
50. Berge E, Whiteley W, Audebert H, Marchis
GM De, Fonseca AC, Padiglioni C, et al.
European Stroke Organisation (ESO)
guidelines on intravenous thrombolysis
for acute ischaemic stroke. Vol. 6,
European Stroke Journal. 2021. I–LXII.
51. Demaerschalk BM, Kleindorfer DO,
Adeoye OM, Demchuk AM, Fugate JE,
Grotta JC, et al. Scientific Rationale for
the Inclusion and Exclusion Criteria for
Intravenous Alteplase in Acute Ischemic
Stroke A Statement for Healthcare
Professionals from the American Heart
Association/American Stroke Association.
Vol. 47, Stroke. 2016. 581–641 p.
52. Berkhemer OA, Fransen PSS, Beumer D,
van den Berg LA, Lingsma HF, Yoo AJ,
et al. A Randomized Trial of Intraarterial
Treatment for Acute Ischemic Stroke. N
Engl J Med. 2015;372(1):11–20.
53. Goyal M, Demchuk AM, Menon BK,
Eesa M, Rempel JL, Thornton J, et
al. Randomized Assessment of Rapid
Endovascular Treatment of Ischemic
Stroke. N Engl J Med. 2015;372(11):
1019–30..
54. Jovin TG, Chamorro A, Cobo E, de
Miquel MA, Molina CA, Rovira A, et al.
Thrombectomy within 8 Hours after
Symptom Onset in Ischemic Stroke. N
Engl J Med. 2015;372(24):2296–306.
55. Saver JL, Goyal M, Bonafe A, Diener H-C,
Levy EI, Pereira VM, et al. Stent-Retriever
Thrombectomy after Intravenous t-PA
vs. t-PA Alone in Stroke. N Engl J Med.
2015;372(24):2285–95.
56. Campbell BCV, Mitchell PJ, Kleinig TJ,
Dewey HM, Churilov L, Yassi N, et al.
Endovascular Therapy for Ischemic
Stroke with Perfusion-Imaging Selection.
N Engl J Med. 2015;372(11):1009–18.
57. Goyal M, Menon BK, Van Zwam WH,
Dippel DWJ, Mitchell PJ, Demchuk
AM, et al. Endovascular thrombectomy
after large-vessel ischaemic stroke: A
meta-analysis of individual patient data
from five randomised trials. Lancet.
2016;387(10029):1723–31.
58. Powers WJ, Derdeyn CP, Biller J, Coffey
CS, Hoh BL, Jauch EC, et al. 2015
American Heart Association/American
stroke association focused update
of the 2013 guidelines for the early
management of patients with acute
ischemic stroke regarding endovascular
treatment: A guideline for healthcare
professionals from the American . Stroke.
2015;46(10):3020–35..
59. Petty GW, Brown RD, Whisnant JP,
Sicks JD, O’Fallon WM, Wiebers DO.
Ischemic Stroke Subtypes. Stroke.
2000;31(5):1062–8.